NCT01626404

Screening for Advanced Heart Failure Treatment (SEE-HF)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 99 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Advanced heart failure therapy (heart transplantation or LVAD) is underutilized and patients are underserved. The purpose of this prospective, observational study is to obtain multi-center data on the proportion of patients with CRT and/or ICD who are candidates for advanced heart failure treatment and obtain insights into patient and physician decisions regarding referral for advanced heart failure therapy.

Conditions

• Advanced Heart Failure
• CRT and/or ICD

Timeline

• Start date: 2012-10-01
• Primary completion: 2016-02-01
• Completion: 2016-02-01
• First posted: 2012-06-22
• Last updated: 2022-06-24

Locations

7 sites across 6 countries: Denmark, France, Germany, Netherlands, Sweden, United Kingdom